바이러스 제거 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Virus Filtration Market size is expected to reach USD 21.74 Billion in 2034 from USD 6.74 Billion (2025) growing at a CAGR of 13.89% during 2026-2034.

The global virus filtration market is growing steadily due to increasing demand for safe and contamination-free pharmaceutical and biotechnology products. Virus filtration technologies are used to remove viruses from biological products during the manufacturing process. These systems play a critical role in ensuring the safety of vaccines, blood products, and biopharmaceutical drugs.

Several factors are driving the growth of the virus filtration market. The rapid expansion of the biotechnology and pharmaceutical industries is increasing the need for advanced filtration technologies. In addition, strict regulatory standards for biological drug production are encouraging manufacturers to adopt reliable virus removal systems. Technological advancements in membrane filtration and nanofiltration are also improving the efficiency of virus filtration processes.

The future outlook of the virus filtration market appears promising as demand for biologics and advanced therapeutics continues to rise. Pharmaceutical companies are investing in improved manufacturing processes to ensure product safety and quality. As research in biotechnology expands, virus filtration technologies will remain essential for maintaining high standards in drug production.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables
• Instruments
• Services

By Application

• Biologicals
• Medical Devices
• Water Purification
• Air Purification

By End-Use

• Biopharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Medical Device Companies
• Academic Institutes & Research Laboratories

COMPANIES PROFILED

• Merck KGaA, Danaher, Sartorius AG, Thermo Fisher Scientific Inc, GE HealthCare, Charles River Laboratories, Asahi Kasei Medical Co Ltd, WuXi AppTec, Lonza, Clean Biologics
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VIRUS FILTRATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VIRUS FILTRATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biologicals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Water Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Air Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VIRUS FILTRATION MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Biopharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Institutes & Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VIRUS FILTRATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL VIRUS FILTRATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Merck KGaA
  • 9.2.2 Danaher
  • 9.2.3 Sartorius AG
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 GE HealthCare
  • 9.2.6 Charles River Laboratories
  • 9.2.7 Asahi Kasei Medical Co. Ltd
  • 9.2.8 WuXi AppTec
  • 9.2.9 Lonza
  • 9.2.10 Clean Biologics